Beckley Psytech reports initial positive data from TRD treatment trial
Early analysis revealed a rapid antidepressant response in 55% of the BPL-003 treated subjects by the second day.
Early analysis revealed a rapid antidepressant response in 55% of the BPL-003 treated subjects by the second day.
In the trial, mRNA-1283 elicited a higher immune response against the SARS-CoV-2 virus, compared to mRNA-1273.222.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Gedeon Richter adopts TransPerfect’s trial management solutions
Artificial intelligence identified two evolutionary pathways of prostate cancer
BeiGene spin-out Pi Health raises $30m to uptick cancer trial enrolment
Psychedelic treatments for mental health: Is there substance behind the hype?